Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 847547, 10 pages
http://dx.doi.org/10.1155/2014/847547
Research Article

Formulation and Evaluation of Thermosensitive Biogels for Nose to Brain Delivery of Doxepin

Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai 400 098, India

Received 8 February 2014; Accepted 26 May 2014; Published 18 June 2014

Academic Editor: Kamla Pathak

Copyright © 2014 Anuja Naik and Hema Nair. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. K. Vyas, A. Shahiwala, S. Marathe, and A. Misra, “Intranasal drug delivery for brain targeting,” Current Drug Delivery, vol. 2, no. 2, pp. 165–175, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Sharma, P. Choudhari, and P. Kasture, “Recent trends in nasal drug delivery-an overview,” 2006, http://www.pharmainfo.net/reviews/recent-trends-nasal-drug-delivery-system-overview.
  3. R. Krishnamoorthy and A. K. Mitra, “Prodrugs for nasal drug delivery,” Advanced Drug Delivery Reviews, vol. 29, no. 1-2, pp. 135–146, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Khan, K. Patil, N. Bobade, P. Yeole, and R. Gaikwad, “Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats,” Journal of Drug Targeting, vol. 18, no. 3, pp. 223–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Majithiya, P. K. Ghosh, M. L. Umrethia, and R. S. R. Murthy, “Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan,” AAPS PharmSciTech, vol. 7, no. 3, pp. E80–E86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Farid, M. A. Etman, A. H. Nada, and A. E. A. R. Ebian, “Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts,” AAPS PharmSciTech, vol. 14, no. 2, pp. 712–718, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. S. Mahajan and S. Gattani, “In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits,” Drug Delivery, vol. 17, no. 1, pp. 19–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-J. Cho, P. Balakrishnan, E.-K. Park et al., “Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride,” Journal of Pharmaceutical Sciences, vol. 100, no. 2, pp. 681–691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. V. Gowda, D. Tanuja, M. S. Khan, J. Desai, and H. G. Shivakumar, “Formulation and evaluation of in-situ gel of diltiazem hydrochloride for nasal delivery,” Der Pharmacia Lettre, vol. 3, no. 1, pp. 371–381, 2011. View at Google Scholar · View at Scopus
  10. S. Talegaonkar and P. R. Mishra, “Intranasal delivery: an approach to bypass the blood brain barrier,” Indian Journal of Pharmacology, vol. 36, no. 3, pp. 140–147, 2004. View at Google Scholar · View at Scopus
  11. L. Illum, “Transport of drugs from the nasal cavity to the central nervous system,” European Journal of Pharmaceutical Sciences, vol. 11, no. 1, pp. 1–18, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Illum, “Is nose-to-brain transport of drugs in man a reality?” Journal of Pharmacy and Pharmacology, vol. 56, no. 1, pp. 3–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Dondeti, H. Zia, and T. E. Needham, “In vivo evaluation of spray formulations of human insulin for nasal delivery,” International Journal of Pharmaceutics, vol. 122, no. 1-2, pp. 91–105, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. S. S. Pisal, A. R. Paradkar, K. R. Mahadik, and S. S. Kadam, “Pluronic gels for nasal delivery of vitamin B12. Part I: preformulation study,” International Journal of Pharmaceutics, vol. 270, no. 1-2, pp. 37–45, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. I. M. Van der Lubben, J. C. Verhoef, G. Borchard, and H. E. Junginger, “Chitosan and its derivatives in mucosal drug and vaccine delivery,” European Journal of Pharmaceutical Sciences, vol. 14, no. 3, pp. 201–207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Illum, I. Jabbal-Gill, M. Hinchcliffe, A. N. Fisher, and S. S. Davis, “Chitosan as a novel nasal delivery system for vaccines,” Advanced Drug Delivery Reviews, vol. 51, no. 1–3, pp. 81–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Chenite, M. Buschmann, D. Wang, C. Chaput, and N. Kandani, “Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions,” Carbohydrate Polymers, vol. 46, no. 1, pp. 39–47, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Chien, K. Su, and S. Chang, “Anatomy and physiology of the nose,” in Nasal Systemic Drug Delivery, vol. 39, pp. 5–12, Marcel Dekker, 1989. View at Google Scholar
  19. N. Eliezer, J. Sadé, A. Silberberg, and A. C. Nevo, “The role of mucus in transport by cilia,” American Review of Respiratory Disease, vol. 102, no. 1, pp. 48–52, 1970. View at Google Scholar · View at Scopus
  20. British Pharmaceutical Codex, The Pharmaceutical Press, London, UK, 1968.
  21. J. Bernstein, “Method for treatment of headache,” US Patent 6096738, Winston laboratories, 2000. View at Google Scholar
  22. X. Liu, L. Ma, Z. Mao, and C. Gao, “Chitosan-based biomaterials for tissue repair and regeneration,” Advances in Polymer Science, vol. 244, no. 1, pp. 81–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. A. Morris, M. S. Kök, S. E. Harding, and G. G. Adams, “Polysaccharide drug delivery systems based on pectin and chitosan,” Biotechnology and Genetic Engineering Reviews, vol. 27, pp. 257–284, 2010. View at Google Scholar · View at Scopus
  24. P. He, S. S. Davis, and L. Illum, “In vitro evaluation of the mucoadhesive properties of chitosan microspheres,” International Journal of Pharmaceutics, vol. 166, no. 1, pp. 75–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-L. Cao, X.-W. Ren, Q.-Z. Zhang et al., “In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate,” International Journal of Pharmaceutics, vol. 365, no. 1-2, pp. 109–115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. MacChione, G. Lorenzi-Filho, E. T. Guimarães, V. B. C. Junqueira, and P. H. N. Saldiva, “The use of the frog palate preparation to assess the effects of oxidants on ciliated epithelium,” Free Radical Biology and Medicine, vol. 24, no. 5, pp. 714–721, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. T. J. Aspden, J. Adler, S. S. Davis, Ø. Skaugrud, and L. Illum, “Chitosan as a nasal delivery system: evaluation of the effect of chitosan on mucociliary clearance rate in the frog palate model,” International Journal of Pharmaceutics, vol. 122, no. 1-2, pp. 69–78, 1995. View at Google Scholar · View at Scopus
  28. N. G. M. Schipper, S. Olsson, J. A. Hoogstraate, A. G. DeBoer, K. M. Vårum, and P. Artursson, “Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement,” Pharmaceutical Research, vol. 14, no. 7, pp. 923–929, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. H. G. Vogel, “Antidepressant activity: despair swim test,” in Drug Discovery and Evaluation Pharmacological Assays, pp. 559–560, Springer, New York, NY, USA, 2nd edition, 2002. View at Google Scholar